A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma

Frank Stenner,Rahel Chastonay,Heike Liewen,Sarah R. Haile,Richard Cathomas,Christian Rothermundt,Raffaele Daniele Siciliano,Susanna Stoll,Alexander Knuth,Tomáš Büchler,Camillo Porta,Christoph Renner,Panagiotis Samaras

A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma

2012

Frank Stenner
Rahel Chastonay
Heike Liewen
Sarah R. Haile
Richard Cathomas
Christian Rothermundt
Raffaele Daniele Siciliano
Susanna Stoll
Alexander Knuth
Tomáš Büchler
Camillo Porta
Christoph Renner
Panagiotis Samaras

Objective: To evaluate the optimal sequence for the receptor tyrosine kinase inhibitors (rTKIs) sorafenib and sunitinib in metastatic renal cell cancer.

Keywords:

Pathology
Receptor Tyrosine Kinase Inhibitors
Cancer research
Receptor tyrosine kinase
Metastatic renal cell cancer
Progression-free survival
Tyrosine-kinase inhibitor
Medicine
Sorafenib
Renal cell carcinoma
Pharmacology
Sunitinib
pooled analysis
disease free survival
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations